Creatine for Older Adults: Muscle, Brain, and Bone

Creatine monohydrate has been studied for athletic performance for decades. The emerging evidence for its role in healthy aging — across muscle, brain, and bone — has quietly become one of the more compelling stories in nutrition science for older adults. For adults over 60, the argument for creatine supplementation is substantially stronger than most people realize.

Sarcopenia: Creatine’s Primary Target in Aging

Adults gradually lose muscle mass with age — estimates from imaging studies suggest roughly 3 to 8% per decade after age 30, accelerating after 60. The same trend shows up as falling strength and function and is one of the drivers of frailty, fall risk, and loss of independence. Several meta-analyses have shown that creatine supplementation combined with resistance training in older adults produces greater gains in lean mass and strength than resistance training plus placebo. Devries and Phillips’ 2014 meta-analysis pooled trials in adults over about 50 and reported additional lean mass gains on the order of about 1.3 kg with creatine plus training. Without formal resistance training the additional benefit is smaller, but the combination is consistently the best-supported intervention.

Brain Health: The Emerging Evidence

The brain uses phosphocreatine to rapidly regenerate ATP during cognitive demand. Older adults tend to have lower brain creatine content than younger adults on magnetic resonance spectroscopy. Several short-term RCTs have found that creatine supplementation improves performance on memory and processing-speed tasks, particularly under conditions of cognitive stress (sleep deprivation, hypoxia, or in older participants). The Avgerinos 2018 systematic review found a consistent positive signal for memory in healthy older adults, with smaller or null effects in young, well-rested participants. Whether these short-term cognitive effects translate into reduced dementia risk over long timescales is not yet established, but the mechanistic logic and short-term data are encouraging.

Bone Density: The Least-Known Benefit

Creatine supplementation alongside resistance training has improved bone outcomes in some trials in postmenopausal women and older men — populations at meaningful osteoporosis risk. A 12-month RCT by Chilibeck and colleagues in postmenopausal women on a supervised resistance-training program found that 0.1 g/kg/day creatine slowed loss of femoral neck bone mineral density compared with placebo. Trials in older men have shown more mixed bone outcomes. The proposed mechanism involves creatine’s support of osteoblast (bone-forming cell) energy metabolism plus an indirect effect via larger training-induced gains in muscle force on bone.

The dose for healthy aging is well-established: 3 to 5 g of creatine monohydrate daily, with no loading phase required. Creatine monohydrate is the form with the largest evidence base; expensive alternative forms (creatine HCL, buffered creatine) have not been shown to be more effective. People with significant kidney disease should discuss creatine with their clinician before starting, since creatine modestly raises serum creatinine via non-pathologic pathways.